4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online

5479
NeuroFM: A Neuropathology-optimized Foundation Model For Enhanced Diagnostic Accuracy In Alzheimer's Disease And Related Dementias
Poster Presenter
Authors
Ruchika Verma, Shrishtee Kandoi, Robina Afzal, Shengjia Chen, Jannes Jegminat, Michael Karlovich, Melissa Umphlett, Timothy Richardson, Kevin Clare, Quazi Hossain, Jorge Samanamud, Phyllis Faust, Elan Louis, Ann McKee, Thor Stein, Jonathan Cherry, Jesse Mez, Dalilah Quintana Mora, Melissa Nirenberg, Ruth Walker, Susan Morgello, Dennis Dickson, Melissa Murray, Carlos Cordón-Cardo, Nadejda Tsankova, Jamie Walker, Diana Dangoor, Stephanie McQuillan, Emma Thorn, Claudia De Sanctis, Shuying Li, Thomas Fuchs, Kurt Farrell, John Crary, Gabriele Campanella
Affiliations
Icahn School of Medicine at Mount Sinai, New York, NY, USA, Columbia University, New York, NY, USA, University of Texas Southwestern Medical Center, Dallas, TX, USA, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA, Mayo Clinic, Jacksonville, FL, USA, Memorial Sloan-Kettering Cancer Center, New York, NY, USA, Miami University, Oxford, OH, USA
Part of Topic
NeuroFM: A Neuropathology-optimized Foundation Model For Enhanced Diagnostic Accuracy In Alzheimer's Disease And Related Dementias
Accurate neuropathological diagnosis of Alzheimer's disease (AD) and related dementias requires recognizing subtle morphological patterns across brain regions. This expertise is scarce and prone to interobserver variability. Current AI pathology foundation models1 are trained primarily on non-neural, neoplastic surgical tissue, likely limiting their performance on CNS disease and leaving a gap in computational neuropathology. We introduce NeuroFM, a domain-specialized foundation model trained on ~1 billion tiles from 585,657 whole-slide images (80% brain tissue), using a DINOv2 self-supervised architecture with GMA attention. NeuroFM outperformed five general-purpose pathology models on 12 of 59 downstream neuropathology tasks, establishing a new benchmark for AI-assisted dementia diagnosis.
Comments
Email is required but is not shown publicly.
Loading comments...
